American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...
South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...
Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...
The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...
South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...
South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...
On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...
Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...
The Netherlands Ministry of Health, Sports and Welfare has announced an additional EUR 14 million contribution to Norway...
South Korea-based SK bioscience recently announced that Dr Jean Kaseya, Director General, African Centers...
South Korea-based International Vaccine Institute (IVI) has partnered with KEMRI-Wellcome Trust Research Programme (KWTR...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...
Australia-based Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation fro...
Patrick Bergstedt, Senior Vice President, and Head of Emerging Markets, Moderna As the world is progressively reboundin...
The Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and the Roya...
The Ministry of Health and Welfare in South Korea has announced that the Ministry and the Asian Development Bank (ADB) a...
A novel glycoengineering platform, created by the researchers at Yong Loo Lin School of Medicine, National University of...
British pharmaceutical firm GlaxoSmithKline (GSK) has reached an exclusive agreement with Chongqing Zhifei Biologic...
At the recently held 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundati...
The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, and the Institut Pasteur de Dakar (IPD...
Dr Deckster Tonny SAVADYE, CEO of Zimbabwe National Biotechnology Authority (NBA), and Dr Yang Yili, Internati...
